Assertio Holdings Files 2024 10-K
Ticker: ASRT · Form: 10-K · Filed: 2025-03-12T00:00:00.000Z
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceutical
TL;DR
Assertio Holdings filed its 2024 10-K, detailing FY24 financials. Check it out.
AI Summary
Assertio Holdings, Inc. filed its 2024 10-K on March 12, 2025, reporting on its fiscal year ending December 31, 2024. The company, operating in pharmaceutical preparations, is headquartered in Lake Forest, Illinois. The filing details its financial performance and business operations for the year.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Assertio's financial health and strategic direction for the fiscal year 2024, crucial for investment decisions.
Risk Assessment
Risk Level: medium — The filing is a standard annual report and does not inherently indicate new risks beyond those typical for a publicly traded pharmaceutical company.
Key Players & Entities
- Assertio Holdings, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-03-12 (date) — Filing date
- Lake Forest, IL (location) — Company headquarters
FAQ
What were Assertio Holdings' total revenues for the fiscal year ended December 31, 2024?
The filing does not explicitly state the total revenues in the provided snippet, but it does reference financial periods for 2024 and 2023.
What is the Standard Industrial Classification (SIC) code for Assertio Holdings?
The SIC code for Assertio Holdings is 2834, which corresponds to Pharmaceutical Preparations.
When did Assertio Holdings file its 10-K report?
Assertio Holdings filed its 10-K report on March 12, 2025.
What is the state of incorporation for Assertio Holdings?
Assertio Holdings is incorporated in Delaware (DE).
What is the business address of Assertio Holdings?
The business address is 100 S. Saunders Road, Suite 300, Lake Forest, IL 60045.
From the Filing
0001808665-25-000009.txt : 20250312 0001808665-25-000009.hdr.sgml : 20250312 20250312171459 ACCESSION NUMBER: 0001808665-25-000009 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 125 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250312 DATE AS OF CHANGE: 20250312 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Assertio Holdings, Inc. CENTRAL INDEX KEY: 0001808665 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 850598378 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39294 FILM NUMBER: 25732720 BUSINESS ADDRESS: STREET 1: 100 S. SAUNDERS ROAD STREET 2: SUITE 300 CITY: LAKE FOREST STATE: IL ZIP: 60045 BUSINESS PHONE: (224) 419-7106 MAIL ADDRESS: STREET 1: 100 S. SAUNDERS ROAD STREET 2: SUITE 300 CITY: LAKE FOREST STATE: IL ZIP: 60045 10-K 1 asrt-20241231.htm 10-K asrt-20241231 0001808665 false FY 2024 P1M P1M 0.2442003 http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent P1Y http://fasb.org/us-gaap/2024#CostsAndExpenses http://fasb.org/us-gaap/2024#CostsAndExpenses http://fasb.org/us-gaap/2024#CostsAndExpenses http://fasb.org/us-gaap/2024#CostsAndExpenses 375 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure asrt:contingent_value_right asrt:day utr:Rate asrt:lease asrt:claim asrt:segment 0001808665 2024-01-01 2024-12-31 0001808665 2024-06-30 0001808665 2025-03-07 0001808665 2024-12-31 0001808665 2023-12-31 0001808665 us-gaap:ProductMember 2024-01-01 2024-12-31 0001808665 us-gaap:ProductMember 2023-01-01 2023-12-31 0001808665 asrt:RoyaltiesAndMilestonesMember 2024-01-01 2024-12-31 0001808665 asrt:RoyaltiesAndMilestonesMember 2023-01-01 2023-12-31 0001808665 us-gaap:ProductAndServiceOtherMember 2024-01-01 2024-12-31 0001808665 us-gaap:ProductAndServiceOtherMember 2023-01-01 2023-12-31 0001808665 2023-01-01 2023-12-31 0001808665 us-gaap:CommonStockMember 2022-12-31 0001808665 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001808665 us-gaap:RetainedEarningsMember 2022-12-31 0001808665 2022-12-31 0001808665 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001808665 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001808665 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001808665 us-gaap:CommonStockMember 2023-12-31 0001808665 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001808665 us-gaap:RetainedEarningsMember 2023-12-31 0001808665 us-gaap:CommonStockMember 2024-01-01 2024-12-31 0001808665 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-12-31 0001808665 us-gaap:RetainedEarningsMember 2024-01-01 2024-12-31 0001808665 us-gaap:CommonStockMember 2024-12-31 0001808665 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001808665 us-gaap:RetainedEarningsMember 2024-12-31 0001808665 srt:MinimumMember asrt:FurnitureAndOfficeEquipmentMember 2024-12-31 0001808665 srt:MaximumMember asrt:FurnitureAndOfficeEquipmentMember 2024-12-31 0001808665 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2024-12-31 0001808665 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2024-12-31 0001808665 srt:MinimumMember us-gaap:EquipmentMember 2024-12-31 0001808665 srt:MaximumMember us-gaap:EquipmentMember 2024-12-31 0001808665 srt:MinimumMember 2024-01-01 2024-12-31 0001808665 srt:MaximumMember 2024-01-01 2024-12-31 0001808665 asrt:CencoraFormerlyAmerisourceBergenCorporationMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2024-01-01 2024-12-31 0001808665 asrt:CencoraFormerlyAmerisourceBergenCorporationMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2023-01-01 2023-12-31 0001808665 asrt:CencoraFormerlyAmerisourceBergenCorporationMember us-gaa